Consistent with human breast cancer cells (Figure 2B), PD-L1 up-regulation was increased when vorinostat was combined with azacitidine in the 4T1 and EMT6 mouse cell lines (Supplementary Figure 7B). Here, CD274 is linked to breast carcinoma.